ASH2023注目テーマ⑱ 日本からの演題「#889」

T-ALLとT-LBLの移植後のOSは同等、
強力な予後不良因子が明らかに Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy (#889)

名島悠峰（がん・感染症センター都立駒込病院 血液内科）